US PFAS settlements spark debate over adequacy and public health risks

Manufacturers of per‑ and polyfluoroalkyl substances (PFAS) have reached settlements totaling more than $10 billion with public water system operators across the United States. One company alone agreed to pay $10.3 billion, prompting criticism that the payouts may underestimate the chemicals’ long‑term health effects and shield producers from future liability.

PFAS, dubbed “forever chemicals,” are found in drinking water for an estimated 200 million Americans and have been linked by the EPA to cancer, reproductive harm, immune system damage and other serious health issues. Federal and state actions, including EPA drinking‑water limits for six PFAS compounds and billions of dollars in infrastructure funding, aim to curb exposure, but advocates argue that settlement amounts fall short of covering remediation and health costs.